Krystal Biotech, Inc. (KRYS) Tops Q4 EPS by 59c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Evercore ISI Removes Krystal Biotech (KRYS) From Tactical Outperform List
February 26, 2024 11:26 AM ESTEvercore ISI analyst Josh Schimmer reiterated an Outperform rating and $168.00 price target on Krystal Biotech (NASDAQ: KRYS)
Removes from Tactical Outperform List.For an analyst ratings summary and ratings history on Krystal Biotech... More
